Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
about
Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intakeFluoxetine versus other types of pharmacotherapy for depressionTen putative contributors to the obesity epidemicThe Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary CareTreating Chronic Pain with SSRIs: What Do We Know?Depression and the Link with Cardiovascular DiseaseParoxetine-The Antidepressant from Hell? Probably Not, But Caution RequiredEffects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent ratsA comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Observational study of the impact of short-term duloxetine treatment on body weight in patients with major depressive disorder: a taiwanese perspectiveDesvenlafaxine and weight change in major depressive disorderObesity and depression in adolescence and beyond: reciprocal risks.Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample.Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Antidepressant use and diabetes mellitus risk: a meta-analysis.Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studiesProphylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD miceComparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression.Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective StudyThe bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depressionMetabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder.Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey.Impact of concomitant medications on obstructive sleep apnoea.Effect of sertraline on proliferation and neurogenic differentiation of human adipose-derived stem cellsSelective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.Paroxetine Can Enhance Neurogenesis during Neurogenic Differentiation of Human Adipose-derived Stem Cells.Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.Diet-induced changes in the Lean Brain: Hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region.The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials.The Trajectory from Mood to Obesity.Pharmacological Management of Anxiety Disorders in the Elderly.
P2860
Q21134750-0F6F41D4-1C04-48F7-8F3D-2AE877BCD04DQ24245764-7D7D633F-3569-4298-BFBF-52D4908890F5Q24619245-09726621-034E-4650-B821-E36685035F5CQ24682953-B7A5EED5-8EE9-450A-86BC-C1E8C3CF8271Q26738470-DA31C719-FDAE-4FF2-97D3-F92AD33A8923Q26752379-2BD8BD50-D958-4EA0-863C-5752B17BB314Q28069392-F0E963D3-8D20-4C69-925C-4E5EA322415DQ30373410-162FB10F-08B0-4344-B592-6C365298CA9BQ33718185-16B801EC-ED34-420F-9F2E-95F2AE197379Q33902245-7DE16F64-51E9-42F5-B585-3392006B2BC5Q33902252-880D2789-5316-41B1-827F-80DE48ED2329Q33902519-6352A919-26B2-48B5-9F8F-A5E85EF41694Q34049910-DD08EDF2-5607-4E9E-86C7-6C42383FE262Q34106516-CFC95B84-01C4-413B-B164-F49501AADECDQ34243328-C52936C4-098F-4D36-BE18-52FCD3CDCAB3Q34623350-08207B5E-4EA8-4A25-BDDA-5362D280C823Q34886547-8B6EC7D5-4051-4889-8132-B9AA49732FC4Q35574503-2976E986-A9A6-403D-848B-CA78BB4CE516Q35996371-CAE666B9-B9A7-4D18-897C-3B3A140270D7Q36565050-831276B6-1E28-4E43-948E-A88E186CE0A4Q36941575-F3D1FF99-CA82-4F86-BBF3-83361233D622Q37187659-A82F694C-D7B4-4881-82D2-1AC9A1CFBF01Q37397705-7C328816-8D06-4BE9-8B3C-9D69051A489BQ37661052-D6868B7E-5815-4338-ACDE-168AC323B742Q38979483-0E999220-8D5F-4A4C-BC2C-E3966CE22150Q39143491-89808A03-A3C1-4D58-B0B8-2268656CE33CQ39218780-77BBA91A-E063-4A6E-ABC8-F1853CF9F07FQ41992147-6D71EBFE-E81B-4E47-B4AC-FEEDD423D183Q42375205-7DE6D35B-A7BE-4DF2-A195-9F52B3FF8A7AQ42837765-0B11D4ED-02D1-4FFC-8E0F-F9F255413C0FQ43051350-25C050A3-5164-4BF9-A2E2-B6C3C9684455Q47684242-F2D4046C-E37D-4407-A58C-5691874BAEFBQ47758427-09219CCE-F2CE-4574-82E3-7E95433AB1DA
P2860
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@ast
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@en
type
label
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@ast
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@en
prefLabel
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@ast
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@en
P2093
P1476
Fluoxetine versus sertraline a ...... ight with long-term treatment.
@en
P2093
P304
P577
2000-11-01T00:00:00Z